Rheumatology

Your Article Summary

See Latest Articles

Breast cancer in a male with ankylosing spondylitis treated with TNF-alpha antagonists
Joint, Bone, Spine, 06/23/09

Mansouri LE et al. - A 72-year-old male with a 4-year history of TNF-alpha antagonist therapy (infliximab and etanercept) for ankylosing spondylitis was diagnosed with breast cancer. He had a family history of breast cancer. The low incidence and considerable severity of breast cancer in males, genetic risk factors, and potential role for TNF-alpha antagonist therapy are discussed.

Today in Clinical Pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

Rituximab and concomitant leflunomide for the treatment of rheumatoid arthritis
Rheumatology International, 12/15/09

First-line DMARD choice in early rheumatoid arthritis - Do prognostic factors play a role?
Rheumatology, 12/15/09

Use of oral bisphosphonates and risk of venous thromboembolism: A population-based case-control study
Osteoporosis International, 12/15/09

 See all of Clinical Pharmacology

Today in Systemic Lupus (SLE)...keeping you current

Receive free subspecialty "5-minute updates" via email

A single-nucleotide polymorphism of the TNFSF4 gene is associated with systemic lupus erythematosus in Chinese Han populationTEST
Rheumatology International, 12/17/09

Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis
Arthritis Research & Therapy, 12/15/09

Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study
Arthritis Research & Therapy, 12/14/09

 See all of Systemic Lupus (SLE)